Full Text View
Tabular View
No Study Results Posted
Related Studies
Observational Trial of Hepatitis C Virus (HCV) Infected Patients on Calcineurin Inhibitors
This study is currently recruiting participants.
Verified by University of Wisconsin, Madison, January 2009
First Received: January 6, 2009   Last Updated: January 7, 2009   History of Changes
Sponsored by: University of Wisconsin, Madison
Information provided by: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00819026
  Purpose

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.


Condition
Hepatitis C Virus

MedlinePlus related topics: Hepatitis Hepatitis C
U.S. FDA Resources
Study Type: Observational
Study Design: Cross-Sectional

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment: 30
Study Start Date: October 2008
Estimated Study Completion Date: July 2009
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

solid organ transplant patients

Criteria

Inclusion Criteria: - HCV infected on immunosuppression

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00819026

Locations
United States, Wisconsin
University of Wisconsin Recruiting
Madison, Wisconsin, United States, 53706
Contact: Rob Striker, MD/PhD     608-263-2994     rtstriker@wisc.edu    
Principal Investigator: Rob Striker, MD/PhD            
Sponsors and Collaborators
University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: university of Wisconsin ( Rob Striker, Assistant Professor of Medicine )
Study ID Numbers: UWisHCV-1
Study First Received: January 6, 2009
Last Updated: January 7, 2009
ClinicalTrials.gov Identifier: NCT00819026     History of Changes
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Virus Diseases
Hepatitis
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Hepatitis C

Additional relevant MeSH terms:
Virus Diseases
Hepatitis
RNA Virus Infections
Liver Diseases
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Hepatitis C

ClinicalTrials.gov processed this record on May 06, 2009